Immunotherapy Breakthroughs and Single-Cell Atlas Studies Reshape Liver Cancer Care in China
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
Adding nanoparticle albumin-bound paclitaxel to transarterial chemoembolization significantly improved disease control and sharply reduced tumor progression in breast cancer liver ...
A proof-of-concept study shows proton magnetic resonance spectroscopy can detect the chemotherapy drug doxorubicin inside liver tissue after transarterial chemoembolization, ...
An international two-step survey of interventional radiologists reveals that real-world treatment of hepatocellular carcinoma frequently diverges from BCLC guidelines, exposing ...
A UK tertiary liver centre reports that non-thermal irreversible electroporation achieved complete tumour response in nearly 84 percent of early-stage ...
A retrospective Australian cohort study found that a more than twelvefold increase in doxorubicin concentration during conventional transarterial chemoembolization produced ...
A retrospective study finds that transarterial chemoembolization for liver cancer spares the main hepatic arteries but causes significant injury to ...
New research shows that triple therapy for unresectable liver cancer is associated with denser, more mature intratumoral tertiary lymphoid structures ...
A new editorial in CVIR Oncology charts how the Road2IR fellowship programs and SAFIRE's one-radiologist-per-million goal could bring image-guided cancer ...
A Taiwanese retrospective study shows that tumor number and MELD score can identify which intermediate-stage hepatocellular carcinoma patients benefit from ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine